Therapeutics
Search By Attributes
Search Results
| Name | Synonyms | FDA Status | Company | Target Type | Therapy Type | Approved For |
|---|---|---|---|---|---|---|
| Dapagliflozin | Farxiga, Forxiga, BMS 512148 |
Alzheimer's Disease (Phase 1/2) | AstraZeneca, Bristol-Myers Squibb | Other | Small Molecule | |
| Dasatinib + Quercetin | Alzheimer's Disease (Phase 1/2) | Tau, Other | Combination, Small Molecule, Supplement, Dietary | |||
| NSC001 | AF267B , NGX267, NI004 |
Alzheimer's Disease (Phase 1/2) | Neurimmune, TorreyPines Therapeutics, Inc. | Cholinergic System | Small Molecule | None |
| RG6289 | Alzheimer's Disease (Phase 1/2) | Hoffmann-La Roche | Amyloid-Related | Small Molecule |